for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up
Healthcare

BRIEF-AIM Immunotech Says Co, And Shenzhen Smoore Technology Announce Agreement To Research A Potential, Easy-To-Use Treatment Approach For SARS-COV-2

April 6 (Reuters) - AIM ImmunoTech Inc:

* AIM IMMUNOTECH INC - CO, AND SHENZHEN SMOORE TECHNOLOGY ANNOUNCE AGREEMENT TO RESEARCH A POTENTIAL, EASY-TO-USE TREATMENT APPROACH FOR SARS-COV-2

* AIM IMMUNOTECH INC - PURPOSE OF MTA IS TO RESEARCH IN CHINA EFFICACY OF SMOORE'S INHALATION DELIVERY DEVICE USING AMPLIGEN Source; bit.ly/2whRbf5 Further company coverage:

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up